Incyte Corporation
Clinical trials sponsored by Incyte Corporation, explained in plain language.
-
New drug combo shows promise for rare bone marrow cancers
Disease control OngoingThis early-stage study tests a new drug called INCB057643, given alone or with an existing drug (ruxolitinib), for people with myelofibrosis and other advanced blood cancers. The main goal is to check safety and see if the drug can shrink an enlarged spleen, a common problem in t…
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 29, 2026 01:50 UTC
-
New pill may stop relentless itch of prurigo nodularis
Symptom relief OngoingThis study tests an experimental drug called povorcitinib for people with prurigo nodularis, a condition causing intense itching and hard bumps on the skin. About 346 adults aged 18 to 75 will receive either the drug or a placebo to see if it reduces itch and clears lesions over …
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Apr 29, 2026 01:36 UTC